British Columbia-based cannabis producer Canandia has received a sales license for its Delta location from Health Canada effective Jan. 18, 2019, in accordance with the Access to Cannabis for Medical Purposes Regulations (ACMPR).
January 21, 2019 By Grow Opportunity Staff
The Delta facility includes a cultivation, production and research facility which parent company Invictus MD says is designed to optimize production and breeding capabilities.
“We have hit the ground running in 2019, remaining laser focused on our objective to bring new facilities online to cultivate unique strain varieties required for our medical and adult use recreational product portfolio,” said George E. Kveton, president and CEO of Invictus.
“We look forward to supplying the Canadian medical and recreational markets with our menu of exotic cannabis strains,” said Alon Amit, CEO of Canandia.
Canandia represents Invictus’ third cultivation license and second sales license issued by Health Canada under the Cannabis Act and Cannabis Regulations.
Print this page